Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2012
11/15/2012WO2012154271A2 Method and cells for identifying rig-i pathway regulators
11/15/2012WO2012154270A2 Process for biomass conversion to synthesis gas
11/15/2012WO2012154204A1 Hydroxamic acid derivatives and their use in the treatment of bacterial infections
11/15/2012WO2012154194A1 Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (nampt)
11/15/2012WO2012154122A2 A topical formulation for treatment of hyperkeratotic skin
11/15/2012WO2012154121A1 Protein f - a novel haemophilus influenzae adhesin with laminin and vitronectin binding properties
11/15/2012WO2012154109A1 Self -aggregating antimicrobial cyclic peptides comprising beta - tri substituted amino acid residues
11/15/2012WO2012154078A1 Antimicrobially active pharmaceutical composition for parenteral use, and method for producing said composition
11/15/2012WO2012154077A1 Pharmaceutical composition for the treatment of tuberculosis and other infections, and method for producing said composition
11/15/2012WO2012154076A1 Antibacterially active pharmaceutical composition for parenteral use, and method for producing said composition
11/15/2012WO2012153885A1 Rice-fermented food composition containing a rice-sweetened liquid, fermented by means of kimchi lactobacillus, as an effective ingredient, and having antibacterial and antiviral effects
11/15/2012WO2012153854A1 Cytokine-chemokine modulator
11/15/2012WO2012153768A1 Medicinal agent containing pyrmidobenzothiazin-6-imine derivative or salt thereof for prevention and/or treatment of viral infection
11/15/2012WO2012153160A1 Recombinant vaccine against prrs in a viral vector
11/15/2012WO2012153130A1 Salts of 4 -ethyl-1-(2 - phenylethyl) - 8 -phenoxy - 2, 3 - dihydro - 1h - pyrrolo [3, 2 -c] quinoline and their use for treating infections
11/15/2012WO2012152898A1 Treatment of mastitis
11/15/2012WO2012152663A1 New hexahydropyrroloimidazolone compounds
11/15/2012WO2012152317A1 Compounds for use in the treatment of feline retroviral infections
11/15/2012WO2012151715A1 Medicament for treating nephropathgenic avian infectious bronchitis and preparation method thereof
11/15/2012WO2012151687A1 Par1 inhibitors for use in the treatment or prevention of paramyxoviridae infections
11/15/2012WO2012128667A3 Vaccine against transmissible gastroenteritis in pigs and method for using said vaccine
11/15/2012WO2012125693A3 Multifunctional metal nanoparticles having a polydopamine-based surface and methods of making and using the same
11/15/2012WO2012106534A3 Hiv integrase inhibitors
11/15/2012WO2012104738A3 Feminine care absorbent article for use in warm climates
11/15/2012WO2012068366A3 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
11/15/2012WO2011120474A8 Method for inhibiting hiv replication in mammal and human cells
11/15/2012US20120289760 Cytomegalovirus-based immunogenic preparations
11/15/2012US20120289614 Functionalized biodegradable triclosan monomers and oligomers for controlled release
11/15/2012US20120289596 Dermatological Compositions Comprising a Fat or Oil of an Essential Fatty Acid Triglyceride
11/15/2012US20120289591 Antimicrobial Compositions Containing Free Fatty Acids
11/15/2012US20120289590 Hair cosmetic composition
11/15/2012US20120289589 Treatment Of Immune Dysregulation Using Cannabinoid Derivatives
11/15/2012US20120289575 Topical antimicrobial compositions
11/15/2012US20120289569 Inhibitors of ubiquitin e1
11/15/2012US20120289552 Aryl ureas with angiogenesis inhibiting activity
11/15/2012US20120289536 Pharmaceutical Compositions Comprising Colloidal Silicon Dioxide
11/15/2012US20120289532 Method for the production of amorphous rifaximin
11/15/2012US20120289505 Inhibitors of diacylglycerol acyl transferase
11/15/2012US20120289499 Process
11/15/2012US20120289487 Pharmaceutical Use of Multicyclic Compounds as Anti-Aids Agents
11/15/2012US20120289484 Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same
11/15/2012US20120289474 3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO-[4,3-c] ISOQUINOLINE DERIVATIVES
11/15/2012US20120289470 Transmucosal administration of drug compositions for treating and preventing disorders in animals
11/15/2012US20120289459 Antiviral peptides from african swine fever virus which prevent the binding of the virus to dlc8
11/15/2012US20120289458 Treatment of influenza virus infection
11/15/2012US20120289457 Peptide oligonucleotide conjugates
11/15/2012US20120289456 Antimicrobial protein compositions and uses thereof
11/15/2012US20120289455 Monocarbams
11/15/2012US20120289454 Metallodrugs having improved pharmacological properties, and methods of manufacture and use thereof
11/15/2012US20120289452 Compositions and methods for treating and preventing necrosis
11/15/2012US20120288575 Cleanser compositions and methods for using the same
11/15/2012US20120288571 Antimicrobial Agents and Methods of Use
11/15/2012US20120288566 Liquid precursor compositions and uses thereof for a ph-dependant sustained release treatment of oral disorders
11/15/2012US20120288557 Acoustically sensitive drug delivery particles comprising low concentrations of phosphatidylethanolamine
11/15/2012US20120288553 Method for controlling toxicity of metallic particle and low-toxicity composite of metallic nanoparticle and inorganic clay
11/15/2012US20120288552 Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
11/15/2012US20120288538 Vaccine against neoplastic or cancerous lesions caused by human papilloma virus (hpv), procedures, uses and methods
11/15/2012US20120288532 Multi-layered, multiple unit pharmaceutical compositions
11/15/2012US20120288528 Mono-and disaccharide derivatives
11/15/2012US20120288523 Administration route for a composition to protect an animal against rhodococcus equi
11/15/2012US20120288522 Novel Pneumovirus Compositions and Methods For Using the Same
11/15/2012US20120288521 Multi plasmid system for the production of influenza virus
11/15/2012US20120288520 Recombinant Flavivirus Vaccines
11/15/2012US20120288516 Markers of XMRV Infection And Uses Thereof
11/15/2012US20120288515 Synthetic long peptide (slp)-based vaccines
11/15/2012US20120288513 Means for the inhibition of anti-beta1-adrenergic receptor antibodies
11/15/2012US20120288512 Anti-CD70 Antibody-Drug Conjugates and Their Use for the Treatment of Cancer and Immune Disorders
11/15/2012US20120288510 Human antibodies against hepatitis c virus (hcv) and uses thereof
11/15/2012US20120288508 Antibodies against clostridium difficile toxins and uses thereof
11/15/2012US20120288502 Compositions and methods for improving potency and breadth of hiv antibodies
11/15/2012US20120288500 Human monoclonal antibodies to btla and methods of use
11/15/2012US20120288493 Method of inhibitng complement activation with human anti-factor c3 antibodies and use thereof
11/15/2012US20120288492 NOVEL PYRIMIDINE COMPOUNDS AS mTOR AND PI3K INHIBITORS
11/15/2012US20120288484 Cells, compositions and methods
11/15/2012US20120288477 Type of consensus interferon and preparation method thereof
11/15/2012US20120288476 Structure and use of 5' phosphate oligonucleotides
11/15/2012CA2843324A1 Compounds and pharmaceutical compositions for the treatment of viral infections
11/15/2012CA2835876A1 Crystalline salts of (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide and methods of using the same
11/15/2012CA2835874A1 A topical formulation for treatment of hyperkeratotic skin
11/15/2012CA2835688A1 Hepatitis c virus inhibitors
11/15/2012CA2835684A1 Antifungal compositions for the treatment of skin and nails
11/15/2012CA2835628A1 Multiple antigen presenting immunogenic composition, and methods and uses thereof
11/15/2012CA2835522A1 Focused evolution of hiv-1 neutralizing antibodies revealed by crystal structures and deep sequencing
11/15/2012CA2835510A1 Protein f - a novel haemophilus influenzae adhesin with laminin and vitronectin binding properties
11/15/2012CA2835343A1 Stable povidone-iodine compositions with steroids or non-steroidal anti-inflammatories
11/15/2012CA2835321A1 Compounds for use in the treatment of feline retroviral infections
11/15/2012CA2835214A1 Integrin receptor antagonists and their methods of use
11/15/2012CA2834956A1 Recombinant vaccine against prrs in a viral vector
11/15/2012CA2834745A1 Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (nampt)
11/15/2012CA2834621A1 Par1 inhibitors for use in the treatment or prevention of paramyxoviridae infections
11/15/2012CA2834438A1 Treatment of mastitis
11/15/2012CA2817211A1 Hydroxamic acid derivatives and their use in the treatment of bacterial infections
11/14/2012EP2522678A1 Neutralizing antibodies to influenza viruses
11/14/2012EP2522665A1 Crystalline sodium salt of an HIV integrase inhibitor
11/14/2012EP2522659A2 Modulators of ATP-binding cassette transporters
11/14/2012EP2522367A1 Oligomer-protease inhibitor conjugates
11/14/2012EP2522342A1 A topical formulation for treatment of hyperkeratotic skin
11/14/2012EP2521733A2 Human immunodeficiency virus (hiv-1) highly conserved and low variant sequences as targets for vaccine and diagnostic applications
11/14/2012EP2521563A2 Methods and compositions for providing protective immunity in the elderly
11/14/2012EP2521562A1 Ev576 for use in the treatment of viral infections of the respiratory tract
1 ... 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 ... 1798